Similar Items: Safety and feasibility of one-stage neonatal approach for short-segment Hirschsprung’s disease
- The role of gut microbiota in Hirschsprung’s disease: from pathogenic mechanisms to microbiota-targeted therapies
- Does surgical approach affect Hirschsprung-associated enterocolitis risk? A comparison between transanal Swenson-like and endorectal pull-throughs
- Development and validation of early-stage and progression prediction models for chronic kidney disease: a retrospective study
- Deciphering the modulatory role of short-chain fatty acids in Parkinson’s disease via phosphorylation-dependent signaling mechanisms
- Retrospective assessment of the predictors of neonatal and infantile cholestasis with and without liver failure: an experience from Southeast China
- Efficacy and safety of pyrotinib-based regimens in patients with HER2-positive stage III/IV breast cancer: a real-world retrospective study in China